1 |
Kao CF, Chuang CY, Chen CH, Kuo HC. 2008. Human pluripotent stem cells: current status and future perspectives. Chin J Physiol 51: 214-225
|
2 |
Yajima Y, Kawashima S. 2002. Calpain function in the differentiation of mesenchymal stem cells. Biol Chem 383: 757-764
DOI
ScienceOn
|
3 |
Mosekilde L. 2008. Primary hyperparathyroidism and the skeleton. Clin Endocrinol (Oxf) 69: 1-19
DOI
ScienceOn
|
4 |
Raggio CL, Boyan BD, Boskey AL. 1986. In vivo hydroxyapatite formation induced by lipids. J Bone Miner Res 1: 409-415
DOI
|
5 |
Janzen J, Vuong PN. 2001. Arterial calcifications: morphological aspects and their pathological implications. Z Kardiol 90 Suppl 3: 6-11
DOI
|
6 |
Shapiro IM, Golub EE, Kakuta S, Hazelgrove J, Havery J, Chance B, Frasca P. 1982. Initiation of endochondral calcification is related to changes in the redox state of hypertrophic chondrocytes. Science 217: 950-952
DOI
|
7 |
Vaananen HK, Laitala-Leinonen T. 2008. Osteoclast lineage and function. Arch Biochem Biophys 473: 132-138
DOI
ScienceOn
|
8 |
Suda T, Nakamura I, Jimi E, Takahashi N. 1997. Regulation of osteoclast function. J Bone Miner Res 12: 869-879
DOI
ScienceOn
|
9 |
Mundy GR. 2007. Osteoporosis and inflammation. Nutr Rev 65: S147-151
DOI
ScienceOn
|
10 |
Gartner L, Pearce CJ, Saifuddin A. 2009. The role of the plain radiograph in the characterization of soft tissue tumours. Skeletal Radiol 38: 549-558
DOI
ScienceOn
|
11 |
Schmid K, McSharry WO, Pameijer CH, Binette JP. 1980. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 37: 199-210
DOI
ScienceOn
|
12 |
Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. 2004. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89: 4246-4253
DOI
ScienceOn
|
13 |
Persy V, D'Haese P. 2009. Vascular calcification and bone disease: the calcification paradox. Trends Mol Med 15: 405-416
DOI
ScienceOn
|
14 |
Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, Choi Y. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24: 33-63
DOI
ScienceOn
|
15 |
Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508
DOI
ScienceOn
|
16 |
Price PA, Faus SA, Williamson MK. 2001. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 21: 817-824
DOI
ScienceOn
|
17 |
Raisz LG. 1999. Physiology and pathophysiology of bone remodeling. Clin Chem 45: 1353-1358
|
18 |
Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H. 2007. Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 18: 251-259
DOI
ScienceOn
|
19 |
Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 1260-1268
DOI
ScienceOn
|
20 |
Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. 1998. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339: 1972-1978
DOI
ScienceOn
|
21 |
Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH. 2006. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 40: 1483-1493
DOI
ScienceOn
|
22 |
Arnett TR. 2008. Extracellular pH regulates bone cell function. J Nutr 138: 415S-418S
DOI
|
23 |
Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423: 337-342
DOI
ScienceOn
|
24 |
Fukagawa M, Akizawa T. 2006. Calcium abnormalities of dialysis patients. J Bone Miner Metab 24: 160
DOI
|
25 |
Teitelbaum SL, Ross FP. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4: 638-649
DOI
ScienceOn
|
26 |
Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357
DOI
ScienceOn
|
27 |
Roodman GD. 1996. Advances in bone biology: the osteoclast. Endocr Rev 17: 308-332
|
28 |
Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81
DOI
ScienceOn
|
29 |
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51
DOI
ScienceOn
|
30 |
Yoshitake H, Rittling SR, Denhardt DT, Noda M. 1999. Osteopontin-deficient mice are resistant to ovariectomy- induced bone resorption. Proc Natl Acad Sci U S A 96: 8156-8160
DOI
ScienceOn
|
31 |
Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J Jr, Pomerantzeff PM, Laurindo FR. 2008. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 28: 463-470
DOI
ScienceOn
|